Inventor · disambiguated record
Martin Lenter
Also filed as: LENTER MARTIN
13 granted patents·7 pending applications·250 citations·filing 2000–2013
92Inventor score
Top patents by PatentIndex Score
20 records- 0196US7173028B2Pyrimidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2002·Granted Feb 6, 2007·116 cites·11 claims
- 0289US6613879B1FAP-activated anti-tumour compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2000·Granted Sep 2, 2003·46 cites·14 claims
- 0388US8337845B2A-beta binding polypeptidesPARK JOHN E·Filed 2011·Granted Dec 25, 2012·18 cites·12 claims
- 0488US7709480B2Pyrimidine derivativesBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 4, 2010·12 cites·12 claims
- 0584US6638965B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2001·Granted Oct 28, 2003·13 cites·13 claims
- 0682US8420630B2Pyrimidine derivativesDAHMANN GEORG·Filed 2010·Granted Apr 16, 2013·6 cites·12 claims
- 0781US7351719B2Amide compounds having MCH-antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 1, 2008·16 cites·17 claims
- 0877US7452911B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Nov 18, 2008·10 cites·17 claims
- 0976US7160901B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 9, 2007·6 cites·13 claims
- 1075US8618132B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsSTENKAMP DIRK·Filed 2008·Granted Dec 31, 2013·3 cites·8 claims
- 1169US7166615B2Substituted indolinones, preparation thereof and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Jan 23, 2007·3 cites·10 claims
- 1268US8614308B2Nucleic acid molecules encoding A-beta binding polypeptidesPARK JOHN E·Filed 2012·Granted Dec 24, 2013·1 cites·3 claims
- 1356US9211330B2A-beta binding polypeptidesABLYNX NV·Filed 2013·Granted Dec 15, 2015·0 cites·5 claims
- 1450US2005148507A1Method for the production of an N-terminally modified chemotactic factorBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 1550US2003211979A1FAP-activated anti-tumor compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1646US2003232742A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 1745US2002155565A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 1843US2003055052A1FAP-activated anti-tumor compoundsFiled 2001·Application pending·0 cites
- 1942US2004242572A1New carboxamide compounds having melanin concentrating hormone antagonistic activity, pharmaceutical preparations comprising these compounds and process for their manufactureBOEHRINGER INGELHEIM INT·Filed 2003·Application pending·0 cites
- 2040US2013295666A1Crystals of glucokinase regulatory protein (gkrp)BOEHRINGER INGELHEIM INT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Lenter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →